Two Seas Capital »

Indivior shares owned by Two Seas Capital

Quarter-by-quarter ownership of Indivior (INDV) shares owned by Two Seas Capital from 13F filings

Historical chart of Two Seas Capital investment in Indivior

Tip: Access up to 7 years of quarterly data

All positions including Indivior held by Two Seas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior by Two Seas Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $315M 14M 23.07
2023-06-30 $325M 14M 23.80

More positions owned by Two Seas Capital

Indivior Ord (INDV)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Arbutus Biopharma (ABUS)
3M Company (MMM)
Meta Platforms Cl A (META)
Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
Esperion Therapeutics (ESPR)
Sonos (SONO)
Odyssey Marine Expl Com New (OMEX)
Hertz Global Hldgs Com New (HTZ)
Arcutis Biotherapeutics (ARQT)
Hertz Global Hldgs *w Exp 06/30/205 (HTZWW)

View all positions for Two Seas Capital

Top funds holding Indivior

Scopia Management
Vanguard Group
Goldman Sachs Group
Barclays
Bank of America Corporation
Norges Bank Investment Management
Leucadia National Corporation
Artemis Investment Management
Jpmorgan Chase & Co
UBS Group
Mackenzie Financial
Royal London Asset Management
Henderson Group
Jupiter Asset Management
Citigroup

View all funds holding Indivior